Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. / Berg, T J; Snorgaard, O; Faber, J; Torjesen, P A; Hildebrandt, P; Mehlsen, J; Hanssen, K F.

In: Diabetes Care, Vol. 22, No. 7, 01.07.1999, p. 1186-90.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Berg, TJ, Snorgaard, O, Faber, J, Torjesen, PA, Hildebrandt, P, Mehlsen, J & Hanssen, KF 1999, 'Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes', Diabetes Care, vol. 22, no. 7, pp. 1186-90.

APA

Berg, T. J., Snorgaard, O., Faber, J., Torjesen, P. A., Hildebrandt, P., Mehlsen, J., & Hanssen, K. F. (1999). Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care, 22(7), 1186-90.

Vancouver

Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J et al. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care. 1999 Jul 1;22(7):1186-90.

Author

Berg, T J ; Snorgaard, O ; Faber, J ; Torjesen, P A ; Hildebrandt, P ; Mehlsen, J ; Hanssen, K F. / Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. In: Diabetes Care. 1999 ; Vol. 22, No. 7. pp. 1186-90.

Bibtex

@article{0e56a06af50a448f805c449ce1bed73a,
title = "Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes",
abstract = "Impairment of left ventricular diastolic function, possibly caused by increased collagen cross-linking of the cardiac muscle, is common in patients with type 1 diabetes even without coronary artery disease. Advanced glycation end products (AGEs) cross-link tissue collagen and are found within myocardial fibers. The aim of this study was to examine for a possible association between circulating AGEs and left ventricular cardiac function.",
author = "Berg, {T J} and O Snorgaard and J Faber and Torjesen, {P A} and P Hildebrandt and J Mehlsen and Hanssen, {K F}",
year = "1999",
month = jul,
day = "1",
language = "English",
volume = "22",
pages = "1186--90",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association",
number = "7",

}

RIS

TY - JOUR

T1 - Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes

AU - Berg, T J

AU - Snorgaard, O

AU - Faber, J

AU - Torjesen, P A

AU - Hildebrandt, P

AU - Mehlsen, J

AU - Hanssen, K F

PY - 1999/7/1

Y1 - 1999/7/1

N2 - Impairment of left ventricular diastolic function, possibly caused by increased collagen cross-linking of the cardiac muscle, is common in patients with type 1 diabetes even without coronary artery disease. Advanced glycation end products (AGEs) cross-link tissue collagen and are found within myocardial fibers. The aim of this study was to examine for a possible association between circulating AGEs and left ventricular cardiac function.

AB - Impairment of left ventricular diastolic function, possibly caused by increased collagen cross-linking of the cardiac muscle, is common in patients with type 1 diabetes even without coronary artery disease. Advanced glycation end products (AGEs) cross-link tissue collagen and are found within myocardial fibers. The aim of this study was to examine for a possible association between circulating AGEs and left ventricular cardiac function.

M3 - Journal article

VL - 22

SP - 1186

EP - 1190

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 7

ER -

ID: 34079069